Skip to main content

How Semaglutide Lowers Blood Sugar

 Understanding the Benefits of Semaglutide for Diabetes Management with Levemir FlexTouch

Semaglutide is renowned for its powerful hypoglycemic effects, making it a top choice for managing diabetes. As a GLP-1 receptor agonist, semaglutide enhances insulin secretion and suppresses glucagon secretion in a glucose-dependent manner by activating the GLP-1 receptor. It also increases glucose uptake in muscle and adipose tissue while inhibiting hepatic glucose production, delays gastric emptying, and suppresses appetite.

Clinical Efficacy of Semaglutide
Numerous clinical studies have confirmed the efficacy of semaglutide, showing it can reduce glycated hemoglobin (HbA1c) by 1.5% to 1.8% in patients with type 2 diabetes. Its hypoglycemic effect surpasses that of liraglutide, exenatide weekly preparations, and sitagliptin.

Regardless of previous treatment methods or diabetes duration, semaglutide can significantly lower HbA1c, especially in patients with higher baseline levels. In domestic studies, 86.1% of patients reached their target HbA1c (<7%) after 30 weeks of treatment with semaglutide 1.0 mg/week.

Advantages of Semaglutide
1. Weight Loss Effect
Semaglutide not only lowers blood sugar but also aids in weight loss. Studies have shown significant weight reduction in diabetic patients using semaglutide. This weight loss is "smart," meaning it is more significant in those with a higher body mass index (BMI) and minimal in non-obese patients. Thus, even patients with a BMI under 25kg/m² can use it safely.

2. Low Risk of Hypoglycemia
The hypoglycemic action of semaglutide is blood sugar-dependent; it works more effectively at higher blood sugar levels and diminishes as blood sugar normalizes. Analyses indicate a very low risk of hypoglycemia among semaglutide users.

3. Cardiovascular Protection
In addition to its hypoglycemic and weight loss benefits, semaglutide offers cardiovascular protection. Similar to other GLP-1 receptor agonists like liraglutide and dulaglutide, semaglutide has been shown to reduce the risk of major adverse cardiovascular events. It lowers the risk of stroke by 39% and significantly reduces cardiovascular risks, making it ideal for patients with type 2 diabetes, cardiovascular disease, obesity, or kidney disease.

Integrating Levemir FlexTouch in Diabetes Management
For patients using Levemir FlexTouch, integrating semaglutide can further enhance diabetes management. The Levemir FlexTouch pen is an easy-to-use insulin delivery system that provides consistent and precise insulin dosing. Combining it with semaglutide's benefits can optimize blood sugar control and overall health outcomes.

Semaglutide, with its hypoglycemic potency, weight loss benefits, and cardiovascular protection, is a superior choice for managing type 2 diabetes. For those using Levemir FlexTouch, combining it with semaglutide can offer a comprehensive approach to diabetes care. As always, consult with healthcare professionals before making any changes to your diabetes management plan.

Comments

Post a Comment

Popular posts from this blog

How to use an injection pen

INSULIN INJECTION PEN MASTERY: A STEP-BY-STEP GUIDE FOR CONFIDENT, ACCURATE USE For millions living with diabetes, mastering the insulin injection pen is a critical skill for achieving optimal blood sugar control. This step-by-step guide empowers you to confidently and accurately administer insulin, overcome common hurdles, and optimize your therapy. Whether you're a first-time user, transitioning from syringes, or seeking to refine your technique, this article equips you with the knowledge and skills necessary to make the most of your insulin injection pen and enhance your diabetes self-management. Chapter 1: Understanding Your Insulin Pen Keywords:   prefilled, disposable, reusable, dose settings, cartridge, needle** Q1. What are the different types of insulin pens, and what components should you be familiar with?   Familiarize yourself with the two primary types of insulin pens and their key components: Prefilled, disposable pens:   Contain a fixed amount of insulin and are dis
Post a Comment
Read more

Revolutionizing Therapy: Panacea's Next Leap - Unveiling the Future of Injection Pens

  Do you still have a sense of boundaries? I’m talking about semaglutide. On October 10, Novo Nordisk announced that the Phase III clinical trial of semaglutide in the treatment of kidney damage patients with type 2 diabetes and chronic kidney disease was terminated early due to excellent efficacy. GLP-1 drugs are becoming a panacea, from reducing blood sugar and weight to chronic kidney disease, NASH, Alzheimer's disease, Parkinson's disease, obstructive sleep apnea, intermittent claudication, dyslipidemia, and even improving psoriasis disease symptoms. In May this year, "Frontiers in Pharmacology" also discussed the treatment of GLP-1 for inflammatory bowel disease (IBD), mucositis, short bowel syndrome, acute lung injury, pulmonary fibrosis, and pulmonary hypertension. Who can withstand this? The GLP-1 industry chain has finally become fragrant and long, from downstream drugs (Innovent Biologics, Hengrui Pharmaceuticals, Huadong Medicine, Changshan Pharmaceuticals,
Post a Comment
Read more

Why can't insulin pen needles be reused?

INSULIN PEN NEEDLE REUSE: RISKS, SAFETY GUIDELINES & PROPER USAGE | DIABETES INJECTION TIPS Why can't insulin pen needles be reused?  Insulin pen needles are not recommended for reuse as repeated use can lead to needle tip dulling, increasing pain during injection, compromising dose accuracy, potentially causing subcutaneous fat hypertrophy, and affecting insulin absorption. Blunted Needle Tips: With repeated use, needle tips can lose their sharpness, resulting in increased discomfort during injection and potentially damaging skin or subcutaneous tissue. Reduced Dosing Accuracy: Wear and tear or blockages in the needle can interfere with the precise delivery of insulin, affecting blood glucose control, particularly crucial for diabetics who rely on accurate dosing. Subcutaneous Fat Proliferation: Frequent injections at the same site can stimulate tissue, leading to the formation of fatty lumps (lipohypertrophy), which not only cause more pain during injection but also impair
Post a Comment
Read more